One shot, three viruses: new vaccine trial for seniors

NCT ID NCT06604767

First seen Jan 31, 2026 · Last updated May 16, 2026 · Updated 14 times

Summary

This early-stage study tested a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. About 390 adults aged 60 and older received different combinations of the vaccine to check safety and whether it helps the body make protective antibodies. The main goal was to see if the vaccine is safe and triggers an immune response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number : 0360001

    Botany, New South Wales, 2019, Australia

  • Investigational Site Number : 0360002

    Camberwell, Victoria, 3124, Australia

  • Investigational Site Number : 0360003

    Bayswater, Victoria, 3153, Australia

  • Investigational Site Number : 0360004

    Miranda, New South Wales, 2228, Australia

  • Investigational Site Number : 0360005

    Kanwal, New South Wales, 2259, Australia

  • Investigational Site Number : 0360006

    Blacktown, New South Wales, 2148, Australia

  • Investigational Site Number : 0360008

    Herston, Queensland, 4006, Australia

  • Investigational Site Number : 0360009

    Brookvale, New South Wales, 2100, Australia

Conditions

Explore the condition pages connected to this study.